Corporate Corruption Media Articles

Excerpts of Key Corporate Corruption Media Articles in Major Media

Below are key excerpts of revealing news articles on corporate corruption from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.

Goldman Sachs will pay about $5 billion to resolve state and federal investigations into its handling of mortgage-backed securities in the years leading up to the 2008 financial crisis, the bank said today. The agreement will settle "actual and potential civil claims" by the U.S. Justice Department and the attorneys general of New York and Illinois, as well as the Federal Home Loan Banks of Chicago and Seattle and the National Credit Union Administration. Goldman said the settlement, an agreement in principle, has not yet been finalized by the parties involved. If it is, it will reduce earnings for the last three months of 2013 by $1.5 billion. Ever since the subprime mortgage crisis upended the global financial system, authorities have been investigating a number of large financial institutions and their sale of mortgage-backed securities. The investigations have centered on whether the banks misrepresented the real value of the assets. Regulators have already won large multibillion-dollar settlements from several large banks, including JPMorgan Chase, Bank of America and Citigroup. Last May, Goldman announced it was negotiating with federal and state authorities to resolve claims against it.

Note: Yet no individual goes to jail for their actions which costs taxpayers billions of dollars. Once again, those who commit white collar crimes go free. And since the bailout in 2008, the percentage of US banking assets held by the big banks has almost doubled. Could this possibly have been planned? For more along these lines, see concise summaries of deeply revealing news articles about corruption in government and in the financial industry.

When does Big Pharma profiting become profiteering? This issue was the subject last month of a Senate Finance Committee investigation of pricing practices of Gilead Sciences Inc., a leading provider of hepatitis C medications. After examining 20,000 pages of internal company documents, looking at Medicaid data and interviewing health care experts, the authors concluded that the Foster City drugmaker “pursued a calculated scheme for pricing and marketing its hepatitis C drug based on one goal: maximizing revenue regardless of the human consequences.” With the hepatitis C virus affecting about 3 million people in the United States, the impact of Gilead’s pricing strategy is real, measurable - and devastating. With a 12-week course of Gilead’s Harvoni priced at nearly $100,000, taxpayer-funded Medicare Part D spent $4.6 billion on hepatitis C alone in the first half of 2015. When insurers refuse to pay for treatment, all but the wealthy are left at risk for cirrhosis, liver cancer and death. While anticipating record profits of $30 billion in 2015, Gilead virtually eliminated its medication assistance program. More than 90 percent of hepatitis C patients can achieve a cure with as little as one pill a day. But to realistically address this epidemic at current pricing levels would bankrupt our health care system. Pharmaceutical innovation holds great promise for the future of our health care system. But not if none of us can afford it.

Note: For more along these lines, see concise summaries of deeply revealing news articles about big pharma profiteering. Then read an in-depth essay titled "The Truth About Drug Companies" by acclaimed author Dr. Marcia Angell.

People rely on unbiased research to find out important statistics about all facets of nutrition. However, recent research from the Charles Perkins Centre at the University of Sydney suggests there is bias in industry-funded research studies ... the full extent of which is still unknown. [Professor Lisa] Bero and her team reviewed 775 reports in the medical literature ... to determine whether nutrition studies funded by the food industry were "associated with outcomes favourable to the sponsor". "Most of the studies only looked at the [author's interpretation] of the research. If it were industry sponsored, they were more likely to have a conclusion that favoured the industry sponsor," Bero said. This latest paper [follows] Bero's previous study which found nutrition studies funded by artificial sweetener companies are more likely to lead to favourable results. So, what happens if more industry sponsored nutrition studies are proven to be biased? "If you look at other areas where the effects of industry sponsorship have been shown, like in the pharmaceutical research area and the tobacco research area, people have actually applied more consistent quality criteria," Bero said. "You'd also want to try to make sure that all the data is being published. In the nutrition area they don't have things like clinical trial registries like they do for drug studies, for example. So if you have a study that's unfavourable or parts of it are unfavourable, it's hard to tell if ... all of it has gotten published. That's a huge bias in the pharmaceutical and tobacco studies."

Note: For more along these lines, see concise summaries of deeply revealing news articles on corruption in the food system and in the scientific community.

The father of the billionaires Charles G. and David H. Koch helped construct a major oil refinery in Nazi Germany that was personally approved by Adolf Hitler, according to a new history of the Kochs and other wealthy families. The book, “Dark Money,” by Jane Mayer, traces the rise of the modern conservative movement through the activism and money of a handful of rich donors. The book is largely focused on the Koch family, stretching back to its involvement in the far-right John Birch Society and the political and business activities of the father, Fred C. Koch, who found some of his earliest business success overseas in the years leading up to World War II. One venture was a partnership with the American Nazi sympathizer William Rhodes Davis, who, according to Ms. Mayer, hired Mr. Koch to help build the third-largest oil refinery in the Third Reich, a critical industrial cog in Hitler’s war machine. The Kochs’ vast political network, a major force in Republican politics today, was “originally designed as a means of off-loading the costs of the Koch Industries environmental and regulatory fights onto others” by persuading other rich business owners to contribute to Koch-controlled political groups. In Ms. Mayer’s telling, the Kochs helped bankroll - through a skein of nonprofit organizations with minimal public disclosure - decades of victories in state capitals and in Washington, often leaving no fingerprints.

Note: Coincidentally, George Bush's grandfather, the late US senator Prescott Bush, was also in business with the Nazis. The conservative political network overseen by the Koch brothers plans to spend $889 million on US elections in 2016. For more along these lines, see concise summaries of deeply revealing elections corruption news articles from reliable major media sources.

Robert Reich, former secretary of labor under President Bill Clinton and a professor of public policy at University of California, Berkeley, spent years warning of twin demons: Technology and globalization. Machines displaced ... workers whose routine jobs could be automated, and globalization meant the flight of manufacturing and service jobs to factories and call centers in emerging countries. The result was ever-widening inequality. In his latest book, “Saving Capitalism: For the Many, Not the Few,” he’s changed his tune. While those two factors still play a role in growing inequality, he cites a new culprit: “the increasing concentration of political power in a corporate and financial elite that has been able to influence the rules by which the economy runs.” [Reich explains], "Capitalism is based on trust. It’s impossible to have a system that works well and is based on billions of transactions if people don’t trust that others are going to fulfill their obligations, or they fear someone will take advantage of them or exploit them. That’s when a system moves from production to protection. Economists have been documenting inequality using various measures, but I haven’t seen much documentation of this issue of power. Political scientists and economists are [reluctant] to get into this field. Economists look at market power and monopolies, but the other areas I’ve talked about - this vicious cycle of compounded wealth and power that changes the rules of the game - economists are really not taking it on."

Note: Read how the market is rigged to grow inequality in this summary of a Robert Reich essay that recently appeared in Newsweek. For more along these lines, see concise summaries of deeply revealing income inequality news articles from reliable major media sources.

A report commissioned by the College of Family Physicians of Canada to examine the relationship between doctors and the pharmaceutical industry is being criticized. The document ... was completed in 2013 and only released this month after a number of doctors challenged the college board to make it public. In one of its key findings, the report notes, "There have been instances in which marketing messages have been portrayed as education and health care and pharmaceutical industries have attempted in this way to influence physicians' behaviour or practices," it says. "Evidence suggests that there could also be significant influence on the behaviour of individuals who may be offered gifts or other forms of support, even when the recipients perceive neither obligation nor influence." The report makes 20 recommendations dealing with issues such as conflict of interest, financial relationships, marketing and other relationships with the pharmaceutical and health care industries. But they don't prevent a doctor with ties to the pharmaceutical industry from serving in leadership positions, sponsoring certain events, or even from contributing to an "unrestricted" education fund. Alan Cassels, a drug policy researcher at the University of Victoria, is critical of the college for sitting on the report as long as it did. He suspects the college held it back because it's "pretty embarrassing."

Note: For more along these lines, see concise summaries of deeply revealing news articles about the corruption of science and big pharma profiteering. Then read an in-depth essay titled "The Truth About Drug Companies" by acclaimed author Dr. Marcia Angell.

The Campbell Soup Company may become the first major U.S. food company to list genetically modified organisms, or GMOs, in its ingredients lists nationwide as it threw its weight behind a national labeling standard. The company announced its support on Thursday for federal regulation of GMO standards, noting it is in favor of federal legislation that would allow the U.S. Food and Drug Administration and the U.S. Department of Agriculture to regulate which foods can be labeled GMOs. The company's support for federal legislation comes as Vermont prepares to implement the Vermont Genetically Engineered Food Labeling Act, which would require a GMO label on food by July 1, 2016, if the food is "entirely or partially produced with genetic engineering." Campbell posted an example of that label on its website and said it was preparing to expand the GMO labeling nationwide even without federal regulations, but to do so would need guidance from the FDA and USDA. The company estimates the new labels could be implemented in approximately 12 to 18 months after it gets guidance from the federal agencies. There is currently no federal standard for what food would constitute a GMO, unlike a food item that is deemed USDA Organic. The World Health Organization defines a GMO as "foods derived from organisms whose genetic material (DNA) has been modified in a way that does not occur naturally, e.g. through the introduction of a gene from a different organism."

Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.

Just months before Rob Bilott made partner at Taft Stettinius & Hollister, he received a call on his direct line from a cattle farmer. The farmer, Wilbur Tennant of Parkersburg, W.Va., said that his cows were dying left and right. He believed that the DuPont chemical company, which until recently operated a site in Parkersburg that is more than 35 times the size of the Pentagon, was responsible. Tennant had tried to seek help locally, he said, but DuPont just about owned the entire town. He had been spurned not only by Parkersburg’s lawyers but also by its politicians, journalists, doctors and veterinarians. Bilott decided right away to take the Tennant case, [and] filed a federal suit against DuPont in the summer of 1999. Dozens of boxes containing thousands of unorganized documents began to arrive at Taft’s headquarters: private internal correspondence, medical and health reports and confidential studies conducted by DuPont scientists. The story that Bilott began to see ... was astounding in its breadth, specificity and sheer brazenness. DuPont was nothing like the [other chemical] corporations he had represented at Taft. "DuPont had for decades been actively trying to conceal their actions. They knew this stuff was harmful, and they put it in the water anyway. These were bad facts." He had seen what the ... tainted drinking water had done to [the Tennants'] cattle. What was it doing to the tens of thousands of people in the areas around Parkersburg who drank it daily from their taps?

Note: Read the complete, detailed account of the lawsuit that exposed DuPont's massively harmful criminality at the link above. Read more about the thousands of people DuPont knowingly poisoned in this article. For more along these lines, see concise summaries of deeply revealing corporate corruption news articles from reliable major media sources.

Seven years ago, the Federal Reserve and the Treasury Department bailed out the largest financial institutions in this country because they were considered too big to fail. But almost every one is bigger today than it was before the bailout. If any were to fail again, taxpayers could be on the hook for another bailout. To rein in Wall Street, we should begin by reforming the Federal Reserve, which oversees financial institutions. Unfortunately, an institution that was created to serve all Americans has been hijacked by the very bankers it regulates. What went wrong at the Fed? The chief executives of some of the largest banks in America are allowed to serve on its boards. During the Wall Street crisis of 2007, Jamie Dimon, the chief executive and chairman of JPMorgan Chase, served on the New York Fed’s board of directors while his bank received more than $390 billion in financial assistance from the Fed. Next year, four of the 12 presidents at the regional Federal Reserve Banks will be former executives from one firm: Goldman Sachs. We would not tolerate the head of Exxon Mobil running the Environmental Protection Agency. And we should not allow big bank executives to serve on the boards of the main agency in charge of regulating financial institutions. Financial reforms must not stop with the central bank. We must reinstate Glass-Steagall and break up the too-big-to-fail financial institutions. The sad reality is that the Federal Reserve doesn’t regulate Wall Street; Wall Street regulates the Fed.

Note: After the bailout in 2008, the percentage of US banking assets held by the big banks has almost doubled. Could this possibly have been planned? And why is the only US presidential candidate talking seriously about bank reform being given little attention by mainstream media? For more along these lines, see concise summaries of deeply revealing news articles about corruption in government and in the financial industry.

Dr. Nav Persaud, a family doctor in Toronto, asked and received thousands of pages of documents from Health Canada, and what he saw made him question the effectiveness of a popular morning sickness drug. But he can't talk about it, because Health Canada forced him to sign a confidentiality agreement, and threatened him with legal action if he makes the data public. Matthew Herder, [a] health law associate professor ... is calling on other doctors, researchers and journalists to bombard Ottawa with their own demands for drug industry data, using [a] new legislative lever written into ... the Protecting Canadians from Unsafe Drugs Act, which was passed late last year. Today, in the Canadian Medical Association Journal, Herder is urging Canadians to use the clause [to request] data that has long been protected by a wall of bureaucratic and corporate secrecy. The European Medicines Agency has started publishing all of the clinical reports submitted as part of drug marketing authorization applications - the same material Health Canada refuses to disclose. Almost half of the drug trials remain secret. [In the US], one group looked at 12 antidepressants, comparing the published studies with the internal FDA assessments. 94 per cent of the published studies were positive, compared to 51 per cent when they included all of the studies assessed by the FDA. The authors concluded that without seeing all the data, drug effectiveness can be exaggerated, leading doctors and patients to assume the medications work better than they do.

Note: For more along these lines, see concise summaries of deeply revealing news articles about government corruption and big pharma profiteering. Then read an in-depth essay titled "The Truth About Drug Companies" by acclaimed author Dr. Marcia Angell.

In the span of a mere 11 days this month, $1 billion in future federal tax payments vanished. As congressional leaders were hastily braiding together a tax and spending bill of more than 2,000 pages, lobbyists swooped in to add 54 words that temporarily preserved a loophole sought by the hotel, restaurant and gambling industries, along with billionaire Wall Street investors, that allowed them to put real estate in trusts and avoid taxes. The small changes, and the enormous windfall they generated, show the power of connected corporate lobbyists to alter a huge bill that is being put together with little time for lawmakers to consider. Some executives at companies with the most at stake are also big campaign donors. The real estate provision, released on Dec. 7, is intended to close a loophole in federal law that has allowed casinos, hotels, restaurant chains and other businesses to raise billions of dollars in cash by spinning off the buildings they own into a separate real estate investment trust, or REIT, without triggering a capital gains tax payment, a potentially big benefit. The revised language drew almost no notice from members of Congress, who were given three days to review a 2,009-page spending plan and the 233-page list of tax breaks before they were asked to vote on the package with almost no debate. Three House lawmakers interviewed just after the vote said they had known nothing about it.

Note: For more along these lines, see concise summaries of deeply revealing government corruption news articles from reliable major media sources.

In May 2009 Congress created a special commission to examine the causes of the financial crisis. Some commission members sought to block consideration of any historical account that might support efforts to rein in runaway bankers. One ... wrote [that] it was important that what they said “not undermine the ability of the new House G.O.P. to modify or repeal Dodd-Frank,” the financial regulations introduced in 2010. Never mind what really happened; the party line, literally, required telling stories that would help Wall Street do it all over again. Which brings me to a new movie the enemies of financial regulation really, really don’t want you to see. “The Big Short” is based on the Michael Lewis book of the same name, one of the few real best-sellers to emerge from the financial crisis. It does a terrific job of making Wall Street skulduggery entertaining. Many influential, seemingly authoritative players, from Alan Greenspan on down, insisted not only that there was no bubble but that no bubble was even possible. And the bubble whose existence they denied really was inflated largely via opaque financial schemes that in many cases amounted to outright fraud - and it is an outrage that basically nobody ended up being punished for those sins aside from innocent bystanders, namely the millions of workers who lost their jobs and the millions of families that lost their homes. While the movie gets the essentials of the financial crisis right, the true story of what happened is deeply inconvenient to some very rich and powerful people.

Note: For more along these lines, see concise summaries of deeply revealing news articles about corruption in government and in the financial industry.

Martin Shkreli ... gained notoriety in August when, as CEO of Turing Pharmaceuticals, he acquired a drug to treat parasitic infections, especially in pregnant women and AIDS patients, and proceeded to hike the price to from $13.50 to $750 per pill. He resigned from Turing Friday after being arrested on unrelated charges of securities fraud at a hedge fund. Shkreli was no doubt a first-class tool. But to focus exclusively on shaming Shkreli risks missing the larger problem, that the American health care system allows opportunists like him to [exploit] the lack of transparency on how drugs are priced in the United States. His price gouging was perfectly legal and even justified under the market-based system that underpins the health care industry. “There’s no law that he has to be ethical,” said [Dr. Jeffrey] Lobosky, author of It's Enough To Make You Sick. “His job is not to make drugs available and save patients. His responsibility is to make a profit for his shareholders.” On paper, Turing is a drug company, but it more closely resembles a private-equity firm: it buys undervalued assets - older drugs already approved by federal regulators - and makes money by charging more than what it paid. Many firms make drugs that are mere copies of others and offer no real therapeutic value, Lobosky said.

Note: The unrepentant profiteering of big pharma and financial industry corruption go hand-in-hand.

Martin Shkreli, the 32-year-old former hedge fund manager notorious for jacking up the price of an obscure but critical drug, was arrested Thursday on securities fraud charges. The charges are unrelated to Shkreli’s leadership of Turing Pharmaceuticals. Instead, the charges brought by the U.S. attorney for the Eastern District of New York are related to Shkreli’s time at Retrophin, another bio-pharmaceutical company he founded, and his time at MSMB Capital Management, a hedge fund. Federal prosecutors alleged that for five years, Shkreli lied to investors in two hedge funds and bio-pharmaceutical company Retrophin, all of which he founded. After losing money on stock bets he made through one hedge fund, Shkreli allegedly started another and used his new investors’ money to pay off those who had lost money on the first fund. Then, as pressure was building, Shkreli started Retrophin, which was publicly traded, and used cash and stock from that company to settle with other disgruntled investors. Shkreli “engaged in multiple schemes to ensnare investors through a web of lies and deceit,” U.S. Attorney Robert L. Capers told reporters. “His plots were matched only by efforts to conceal the fraud, which led him to operate his companies ... as a Ponzi scheme.” At his arraignment Thursday afternoon, Shkreli pleaded not guilty. He was released on $5 million bond.

Note: The unrepentant profiteering of big pharma and financial industry corruption seem to go hand-in-hand for Martin Shkreli.

A gun once owned by a Delray Beach arms dealer is among those linked to the Paris attacks that killed 130 people, the head of a Serbian arms factory told The Associated Press. The M92 semi-automatic pistol’s serial number matched one the Zastava arms factory delivered in May 2013 to the family-owned Century International Arms in Delray Beach. Century, a buyer and re-seller of military-grade surplus guns, is one of the largest arms dealers in the United States. This is not the first time that Century Arms has wound up in headlines. In 2011, The Palm Beach Post detailed how Century Arms has prospered - trading in pistols, sniper rifles and assault weapons, sometimes with the help of “unauthorized brokers” - based on secret diplomatic cables made public by WikiLeaks. In 1987, John Rugg, a former police officer and longtime Century Arms employee, told a U.S. Senate committee that the company was involved in supplying arms, including rockets and grenades, to the Contras of Nicaragua during the 1980s-era Iran-Contra scandal. Marc Adler, president of Allan Adler, a Boca Raton consulting firm that specializes in firearms, said taking a handgun out of the country involves reams of paperwork and approval by federal agencies. “The export of firearms is very heavily regulated,” said Adler, who questions how the gun could have legally left the country. “The only way I think it can happen would be some type of illegal transfer.”

Note: If you read between the lines, it's not a stretch to believe that this Delray firm is a CIA front agency or otherwise services the secret parallel US government. For more along these lines, see concise summaries of deeply revealing news articles about corporate corruption and terrorism.

A group formed this year by executives and lobbyists for the defense contracting industry is taking credit for “driving the national debate on foreign policy during the 2016 presidential election,” and in particular for getting Republican presidential candidates to call for escalating military action in Syria. In an email to supporters over the weekend, Mike Rogers, the founder of Americans for Peace, Prosperity, and Security, hailed the group for “pushing candidates on national security.” The email also highlighted a quote from Jeb Bush at an APPS forum calling for the U.S. to be prepared for a “long haul” war on ISIS, and a similar comment from Sen. Marco Rubio, R-Fla., who said the U.S. should engage ISIS as it had against the Taliban in Afghanistan. APPS was formed by current and former officials from Raytheon, BAE Systems, SAIC, and other major defense contractors. Lobbyists who represent the defense industry are also involved. Rogers, the former House Intelligence Committee chairman who retired from Congress last year, also represents private clients. To “help elect a president who supports American engagement and a strong foreign policy,” the group spends money on public events in primary states and encourages presidential candidates to take hawkish positions.

Note: For more along these lines, see concise summaries of deeply revealing news articles about government corruption and the manipulation of public perception.

A panel of scientists is disputing a World Health Organization report published earlier this year that concluded glyphosate, the world's most widely used weed killer and main ingredient in Monsanto Co's Roundup herbicide, is probably carcinogenic to humans. The 16-member panel, assembled by Intertek Scientific & Regulatory Consultancy, will present its findings to the annual meeting of the Society for Risk Analysis on Monday, aiming to publish the study at a later date after peer review. Monsanto paid Intertek for the panel's work. Concerns about glyphosate on food have been a hot topic of debate in the United States recently and contributed to the passage in Vermont last year of the country's first mandatory labeling law for foods that are genetically modified. Critics say that industry-linked scientists are downplaying the risk to human health and trying to discredit the IARC report by casting doubt on some of the scientific studies that it reviewed. Ten of the 16 scientists on the Intertek panel have been consultants for Monsanto in the past and two others are former Monsanto employees.

Note: Read an informative article titled "Monsanto Charged With Crimes Against Humanity" on mercola.com. Read how the EPA used industry studies while ignoring independent studies to declare Roundup safe. For more along these lines, see concise summaries of deeply revealing GMO news articles from reliable major media sources.

Soon after launching a brutal air and ground assault in Yemen, the Kingdom of Saudi Arabia began devoting significant resources to a sophisticated public relations blitz. Elements of the charm offensive include the launch of a pro-Saudi Arabia media portal operated by high-profile Republican campaign consultants; a special English-language website devoted to putting a positive spin on the latest developments in the Yemen war; glitzy dinners with American political and business elites; and a non-stop push to sway reporters and policymakers. That has been accompanied by a spending spree on American lobbyists with ties to the Washington establishment. Saudi Arabia continues to be a leading driver of Sunni terror networks worldwide, including in Syria and Iraq. The Saudi Arabian government is currently supplying weapons to a Syrian rebel coalition that includes the Nusra Front, al Qaeda’s affiliate in the region. Private donors in Saudi Arabia have also worked as fundraisers for the Islamic State, or ISIS. And there is a renewed, bipartisan push by lawmakers to declassify the 28 pages of the 9/11 Commission Report, a censored section that reportedly relates to Saudi state support for al Qaeda’s operation. In September, the Kingdom helped sponsor opulent galas for Washington’s business elite at the Ritz Carlton and the Andrew Mellon Auditorium. The events were attended by King Salman, along with the chief executives of General Electric and Lockheed Martin, the chairman of Marriott International, and prominent think tank officials.

Note: A carefully researched report on the covert origins of ISIS suggests the creation of terrorists is useful for Washington's elite. A document that is reported to connect Saudi money to 9/11 remains classified. For more along these lines, see concise summaries of deeply revealing news articles about government corruption and media manipulation.

The new movie Consumed tackles the controversial world of Genetically Modified Organisms (GMOs) in unprecedented fashion, offering insight into their risks. Its message could not be more timely in the wake of the recent news that the Food and Drug Administration has approved the first genetically engineered salmon for human consumption. The fish, like all genetically engineered ingredients in this country, will not be labeled, leaving American consumers in the dark. Like many food and environmental safety activists around the world, I’m outraged. The biotech industry and the FDA have hijacked not only our basic rights as consumers, but also our fundamental human rights in the face of corporate monopolization of our food supply. They are jeopardizing our health and the environment more than ever before. In detailed comments submitted to the FDA, Michael Hansen, senior scientist at Consumers Union, argues the FDA review process was based on “sloppy science” and the genetically engineered salmon could pose many risks. “Because FDA’s assessment is inadequate, we are particularly concerned that this salmon may pose an increased risk of severe, even life-threatening allergic reactions,” he writes. The majority of Americans ... believe they have a fundamental right to know what is in their food. A 2013 New York Times poll found that 93% of Americans want GMOs to be labeled. More than 60 countries label GMOs, and in some cases even ban them, but the U.S. still does not.

Note: Read an excellent mercola.com article titled "GMO cookie is crumbling." For more along these lines, see concise summaries of deeply revealing GMO news articles from reliable major media sources.

In approving genetically engineered salmon as safe to eat and safe for the environment, the Food and Drug Administration rejected petitions from environmental and food safety groups asking that companies selling this salmon be required to label it as genetically engineered. Congress should overturn that decision. The salmon, made by AquaBounty Technologies of Maynard, Mass., has genes inserted that allow it to grow to market size twice as fast as wild salmon. At least one consumer group has announced plans to sue the F.D.A. to overturn its approval of the engineered salmon. Some leading grocery chains, responding to consumer concerns, have said they won’t sell the genetically engineered salmon. The F.D.A. said there is no reason to mandate labeling because there is no material difference between engineered and natural fish. But the value of that information should be left to consumers to decide. Vermont enacted a law last year that will require labeling of genetically engineered foods starting next July unless a suit filed in June 2014 by four industry trade groups derails it. Other states with strong consumer movements may try to follow. The House passed a bill on July 23, 2015, that would pre-empt states from requiring such labeling, and industry groups are pressing the Senate to attach similar language as a rider to an omnibus spending bill. The Senate should rebuff that tactic and allow states to adopt mandatory labeling laws if they wish.

Note: For more along these lines, see concise summaries of deeply revealing GMO news articles from reliable major media sources.

Important Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.